| Old Articles: <Older 4681-4690 Newer> |
|---|
 |
The Motley Fool
March 27, 2008
Brian Lawler |
A Drugmaker's Candid Thoughts on the FDA Cardiome updates investors on its top two drugs.   |
The Motley Fool
March 26, 2008
Brian Lawler |
Take Two for Depomed The pharmaceutical starts another study for its proposed pain drug. The new study will double the size of patients enrolled and help reduce placebo effects. |
The Motley Fool
March 26, 2008
Brian Lawler |
Celgene Brings in an Orphan The Food and Drug Administration grants a Celgene drug orphan designation. Amrubicin may have an easier time in development for use in a limited patient population. |
The Motley Fool
March 25, 2008
Brian Orelli |
Biovail Hit by a Slow-Moving Truck Biovail finally settles with the SEC, more than four years after the agency started an investigation into the drugmaker. |
InternetNews
March 24, 2008 |
STMicro Launches Microchip to Detect Bird Flu STMicroelectronics, said it has developed a portable chip to detect influenza viruses, including bird flu in humans. |
The Motley Fool
March 24, 2008
Brian Orelli |
Alnylam Authorizes Again The pharmaceutical's latest patent-licensing deal won't be immediately lucrative. |
Chemistry World
March 20, 2008
Richard Van Noorden |
UK Drug Firms to Slash Research and Jobs The UK pharmaceutical industry is expecting to cut jobs and investment in R&D following an alarming slump in confidence in the UK market. |
The Motley Fool
March 20, 2008
Brian Lawler |
Gilead Not Slowing Gilead Sciences gets a new approval for a drug. |
The Motley Fool
March 20, 2008
Brian Lawler |
The AIR's Knocked Out of Alkermes Drug developer Alkermes initiates a round of cost-cutting. |
The Motley Fool
March 20, 2008
Brian Orelli |
Abbott and Takeda's Partnership TAPed Out It looks like Abbott Laboratories and Takeda will be ending their 30-year joint partnership with a 50/50 split. |
| <Older 4681-4690 Newer> Return to current articles. |
